Blog
USDA allocates $21 million to two cannabis research projects
In the most highly developed country in the world, conditions are being actively created for the industrial use of the fibrous part of the hemp plant, including for the manufacture of twisted, textile or knitwear
A visual illustration of a falling CBD market
The desire of companies specializing in the production and sales of CBD products to at least stay in the "bear" market leads not only to significant discounts in sales, but also to active efforts to conquer "new territories" for the sale of their products.
The use of hemp with a high content of THC during pregnancy harms the intrauterine development of the child
Children of mothers who used cannabis during pregnancy are at greater risk of mental disorders than children of those who did not use medical or recreational cannabis during pregnancy. Children whose mothers consumed the THC-enhanced plant during their fetal development are also more likely to experience substance abuse problems later in their teens
National experience in the treatment of diseases associated with the musculoskeletal system with herbal CBD
Despite the lack of generally accepted algorithms for the use of drug-free cannabinoids to solve problems associated with the musculoskeletal system, it can be argued that vegetable cannabidiol shows significant potential when used for the prevention and treatment of this kind of ailments in combination with physical exercises as part of complex therapy.
Lessons to be learned from testing CBD products sold in the UK
72% of the CBD products analyzed by Kent Scientific Services were found to contain higher levels of THC than allowed by current UK law
Trends in the German Medical Cannabis Market
The forecasts of a number of analytical and consulting companies about the exponential growth of the German medical cannabis market clearly did not materialize. Imports of dried flowers and hemp extracts in the first six months of 2022 are only 6.1% higher than in the first half of last year.
Monopoly on the production of medical cannabis in Italy hinders the development of the market
The world's largest sovereign wealth fund is divesting shares of Canadian companies specializing in the legal production of medical and recreational cannabis
The State Pension Fund of Norway, for ethical reasons, is getting rid of shares in companies that are legally engaged in the production of recreational marijuana in Canada. "The Fund does not invest in entities that, themselves or through organizations they control, can produce cannabis for narcotic purposes." It has been announced that Canada's Aurora Cannabis, Canopy Growth Corp, Cronos Group and Tilray Brands will be excluded from the world's largest sovereign government pension fund.
Global hemp market trends on the example of the USA
In the long term, the hemp market in Ukraine will most likely be similar to those of other economically developed countries - a significant part of the hemp planting area will be intended for grain and its fibrous part, and only a small segment of the market will be able to specialize in growing raw materials for the use of therapeutically active hemp ingredients.
Exploiting the therapeutic properties of cannabis could cost pharmaceutical companies billions
Therapeutic properties of the leaves and inflorescences of primarily therapeutic cannabis is becoming a serious competitor in the pharmaceutical market, which can lead to a reduction in sales of conventional pharmaceuticals by almost 11%